Julia A. Haller - Aug 11, 2022 Form 3 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role: Director
Signature: /s/ Lawrence Kenyon, Attorney-in-Fact
Stock symbol: OTLK
Transactions as of: Aug 11, 2022
Transactions value $: $0
Form type: 3
Date filed: 8/15/2022, 05:14 PM
Previous filing: Jul 5, 2022
Next filing: Oct 4, 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned